Having IPOed as recently as June 2015, Finnish healthcare group Pihlajalinna is to ask shareholders for a mandate to issue an extra €40m in shares. The shares have soared 70% above the IPO price to over €17. A €40m issue would leave the company with €70m of net cash. What might the company buy and what does the move tell us about the Finnish market?